Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-23-019367

President and CEO bought 26,000 shares at $2.04 ($53,014)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KIDRON NADAV President and CEO 2023-03-16 Purchase +26,000 $2.04 $53,014 126,000 I
Open-market purchases · 26,000 sh · avg $2.04 · $53,014
Loading xslF345X03/doc4.xml…